Get the Stockscreener App
34.94
14.07%
-5.72
After Hours:
34.88
-0.06
-0.17%
Vericel Corp stock is traded at $34.94, with a volume of 1.87M.
It is down -14.07% in the last 24 hours and down -17.88% over the past month.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$40.66
Open:
$36.98
24h Volume:
1.87M
Relative Volume:
3.48
Market Cap:
$1.76B
Revenue:
$226.84M
Net Income/Loss:
$3.55M
P/E Ratio:
499.14
EPS:
0.07
Net Cash Flow:
$-12.02M
1W Performance:
-12.03%
1M Performance:
-17.88%
6M Performance:
-40.31%
1Y Performance:
-30.84%
1-Day Range:
$34.92
$38.27
1-Week Range:
$34.92
$41.78
52-Week Range:
$34.87
$63.00
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
34.94 | 2.05B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
Canaccord Genuity lowers Vericel stock price target to $58 on burn care outlook - Investing.com Canada
Earnings call transcript: Vericel narrows Q2 loss, stock dips 6.9% By Investing.com - Investing.com South Africa
Vericel shares tumble 7% as revenue misses estimates in Q2 By Investing.com - Investing.com Canada
Vericel shares tumble 7% as revenue misses estimates in Q2 - Investing.com
Vericel Q2 2025 slides: MACI drives 21% revenue growth, margins expand - Investing.com
Vericel Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Vericel Q2 Net Loss Narrows, Revenue Rises; Shares Fall - MarketScreener
Vericel Corp Ord earnings beat by $0.02, revenue fell short of estimates - Investing.com South Africa
Vericel Corp SEC 10-Q Report - TradingView
Vericel Corp Reports Q2 2025 Earnings: EPS of -$0.01 Misses Esti - GuruFocus
Vericel Corporation Reports Second Quarter 2025 Financial Results - TradingView
Universal Beteiligungs und Servicegesellschaft mbH Acquires New Holdings in Vericel Corporation (NASDAQ:VCEL) - Defense World
Vericel Corporation (NASDAQ:VCEL) Shares Bought by Federated Hermes Inc. - Defense World
How Vericel Corporation stock performs during market volatilityFree Weekly Chart Analysis With Entry Advice - Newser
Earnings To Watch: Vericel Corp (VCEL) Reports Q2 2025 Result - Yahoo Finance
Vericel Corporation (NASDAQ:VCEL) Shares Purchased by Meeder Asset Management Inc. - Defense World
Vericel Corporation (NASDAQ:VCEL) Receives $61.14 Average Price Target from Analysts - Defense World
Top chart patterns to watch in Vericel CorporationAI Trade Signal Forecast with Chart Logic - Newser
Vericel Corporation stock volume spike explainedLow Risk Equity Screener With Results Shared - metal.it
What risks could impact Vericel Corporation stock performanceFundamental Growth Stock Analysis Shows Strength - metal.it
Vericel Corporation Included in Top Momentum ScanDaily Volume Spike Trading Signals Detected - metal.it
Teachers Retirement System of The State of Kentucky Buys 4,509 Shares of Vericel Corporation (NASDAQ:VCEL) - Defense World
Vericel Corporation (VCEL): A Bull Case Theory - Insider Monkey
Envestnet Asset Management Inc. Boosts Holdings in Vericel Corporation (NASDAQ:VCEL) - Defense World
Envestnet Asset Management Inc. Has $9.13 Million Holdings in Vericel Corporation (NASDAQ:VCEL) - Defense World
Vericel Corporation Stock Analysis and ForecastRecord-breaking gains - Autocar Professional
Bank of New York Mellon Corp Sells 9,409 Shares of Vericel Corporation (NASDAQ:VCEL) - Defense World
What drives Vericel Corporation stock priceFree Expert Stock Watchlist - Autocar Professional
How high can Vericel Corporation stock price go in 2025Weekly Big Movers - Newser
Nisa Investment Advisors LLC Sells 315 Shares of Vericel Corporation (NASDAQ:VCEL) - Defense World
Cerity Partners LLC Boosts Position in Vericel Corporation (NASDAQ:VCEL) - Defense World
Is Vericel Corporation a good long term investmentFastest-growing stock picks - Jammu Links News
Is Vericel Corporation stock overhyped or has real potential2x 3x 5x Pick Alert - Newser
What institutions are buying Vericel Corporation stock nowVerified Return Tips - newser.com
Vericel Corporation to Report Second-Quarter 2025 Financial Results on July 31, 2025 - Quiver Quantitative
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025 - Yahoo Finance
Vericel Corporation (NASDAQ:VCEL) Shares Sold by Teacher Retirement System of Texas - Defense World
Vericel stock hits 52-week low at $37.38 amid market challenges - Investing.com Nigeria
Vericel stock hits 52-week low at $37.38 amid market challenges By Investing.com - Investing.com South Africa
What makes Vericel Corporation stock price move sharplyFree Stock Movement Tracking - Newser
Why Vericel Corporation stock attracts strong analyst attentionReal Trader Insights - Newser
Vericel stock maintains Buy rating at BTIG despite potential competition By Investing.com - Investing.com Canada
Vericel stock maintains Buy rating at BTIG despite potential competition - Investing.com
Principal Financial Group Inc. Buys 7,222 Shares of Vericel Corporation (NASDAQ:VCEL) - Defense World
Amalgamated Bank Reduces Position in Vericel Corporation (NASDAQ:VCEL) - Defense World
New York State Teachers Retirement System Decreases Stock Position in Vericel Corporation (NASDAQ:VCEL) - Defense World
GAMMA Investing LLC Has $129,000 Holdings in Vericel Corporation (NASDAQ:VCEL) - Defense World
Vericel Corporation (NASDAQ:VCEL) Receives $61.14 Consensus Price Target from Analysts - Defense World
Vericel Corporation(NasdaqGM: VCEL) added to Russell 2000 Defensive Index - MarketScreener
Is Vericel Corp. overvalued or undervalued? - MarketsMojo
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):